Sudden Cardiac Death or Ventricular Arrythmia in Patients Taking Levetiracetam or Oxcarbazepine
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.Levetiracetam (an antiseizure medication) does not increase the risk of sudden cardiac death or ventricular arrhythmia compared to oxcarbazepine. This study suggests no need to restrict levetiracetam use or mandate cardiac monitoring.
Area Of Science
- Cardiology
- Neurology
- Pharmacology
Background
- Levetiracetam is a common antiseizure drug.
- Concerns exist about its potential to prolong the QT interval and increase sudden cardiac death risk.
- This study investigated the cardiac safety of levetiracetam.
Purpose Of The Study
- To assess the association between levetiracetam and cardiac outcomes, specifically QT interval prolongation-related events.
- To compare cardiac outcomes in patients prescribed levetiracetam versus oxcarbazepine.
- To evaluate the safety of levetiracetam in clinical practice.
Main Methods
- Utilized administrative claims data (OptumLabs Data Warehouse) from 2010-2019.
- Included new users of levetiracetam or oxcarbazepine.
- Focused on a composite endpoint of sudden cardiac death or ventricular arrhythmia.
- Employed propensity score weighting and weighted Cox regressions for analysis.
Main Results
- 104,655 patients received levetiracetam and 39,596 received oxcarbazepine.
- Levetiracetam users were older with more comorbidities like epilepsy, hypertension, and coronary artery disease.
- No significant difference in the rate of sudden cardiac death or ventricular arrhythmia was found between the two groups (HR 0.79, 95% CI 0.42-1.47).
Conclusions
- Levetiracetam is not associated with an increased risk of ventricular arrhythmia or sudden cardiac death compared to oxcarbazepine.
- Findings do not support restricting levetiracetam use or requiring cardiac monitoring.
- Class II evidence indicates levetiracetam is safe regarding these cardiac outcomes in patients over 17.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
Focal aware seizures: In these seizures, the person remains conscious...